Navigation Links
Ultragenyx Initiates Phase 1 Clinical Study of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Muscle Wasting Disease
Date:8/15/2011

NOVATO, Calif., Aug. 15, 2011 /PRNewswire/ -- Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced the dosing of the first patient in a Phase 1 study of UX001 for hereditary inclusion body myopathy (HIBM). UX001 is an extended release formulation of sialic acid intended as a substrate replacement therapy for HIBM, a severe, progressive, genetic neuromuscular disease caused by sialic acid deficiency. UX001 is the first program from the company's pipeline to enter the clinic since its founding in 2010.

"Advancing UX001 to the clinic is an important milestone for both Ultragenyx and for patients suffering with HIBM," said Emil D. Kakkis, MD, PhD, Chief Executive Officer of Ultragenyx. "HIBM is one of many rare diseases that lack treatment, but for which good science exists on how it might be treated. Ultragenyx's goal is to be a leader in rare disease therapeutics by rapidly and efficiently transforming existing science into effective treatments for rare diseases that have been neglected in the past."

The Phase 1 clinical study will evaluate the pharmacokinetics (PK) and safety of UX001 in 24 HIBM patients at two centers in New York and Los Angeles. The study will test four different single-dose levels in each group of six subjects. Subjects will then undergo repeat dosing at three dose levels over 7 days to establish the steady-state pharmacokinetics and safety of repeat doses of UX001.  Ultragenyx anticipates data from the Phase 1 study in late 2011.

About HIBM and UX001

HIBM, which is also known as distal myopathy with rimmed vacuoles (DMRV) and Nonaka disease, is a severe, adult-onset muscle disease caused by a defect in an enzyme responsible for the first step of sialic acid biosynthesis.  With deficiency of this enzyme, the patient's muscles are deficient in sialic acid needed for the synthesis of proteins and fats. Pat
'/>"/>

SOURCE Ultragenyx Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. American Regent, Inc. Initiates Voluntary Recall of Seventeen Lots of Vasopressin Injection, USP, Multiple Dose Vials due to Sub-Potency
2. Isis Initiates Phase 1 Study of ISIS-PTP1BRx to Treat Type 2 Diabetes
3. American Regent Initiates Voluntary Nationwide Recall of Calcium Gluconate Injection, USP, 10%, 100 mL Pharmacy Bulk Package Due to Particulates
4. EntreMed Enters into $7.5 Million Equity Facility and Initiates $1.1 Million Drawdown
5. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
6. Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50
7. Naurex Initiates Phase II Clinical Trial of Novel Antidepressant GLYX-13 in Treatment-Resistant Depression
8. Cebix Initiates Phase 1b Clinical Trial with Drug Candidate Ersatta™
9. American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4%, 30 mL Single Dose Vial Due to Particulates
10. Sangart Initiates Phase 2b Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
11. Masimo Initiates Limited Market Release of E1, Single-Patient-Use Ear Sensor for Pulse Oximetry Monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015 Hitachi Chemical Diagnostics, ... States launch of the ExoComplete™ 96-Well Plate ... easy system for exosome collection to mRNA purification.  The ... Vesicles ("ISEV") Annual Meeting, April 23 – 26, 2015, ... are intended for research use only of molecular biology ...
(Date:5/1/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/63gppw/asian_dermatology ) ... Market by Type, by End User - Forecast to 2019" ... Devices market is estimated to grow at a CAGR of ... holds a larger share in the Dermatology devices market around ... The Asian Dermatology Devices market holds a high potential for ...
(Date:5/1/2015)... --  Heska Corporation (NASDAQ: HSKA - ... advanced veterinary diagnostic and other specialty veterinary products , today ... at the 16th Annual B. Riley & Co. Investor Conference ... will be held May 12-14, 2015 at Lowes Hollywood Hotel, ... be available during the day on May 13 for one-on-one ...
Breaking Medicine Technology:New Products for Exosome Isolation to mRNA Purification 2Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 2Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 3Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2
... Pharmaceuticals Inc. (NASDAQ: VNDA ) announced ... Vanda,s sublicensor Novartis Pharma AG, has initiated a ... depot) formulation of Fanapt® (iloperidone).  This is a ... and pharmacokinetic profiles of two different long-acting formulations ...
... Noverca – the first and currently only Italian ,Full ... presence in the Health and Wellness Sector . ... has been developed and launched thanks to the long-term ... o verca) and Fatebenefratelli Hospital. Davide ...
Cached Medicine Technology:Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt® 2Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt® 3EXTENDED HEALTH: Noverca Enters the World of Healthcare 2
(Date:5/4/2015)... MT (PRWEB) May 04, 2015 New ... with Care to Care, LLC to manage outpatient advanced ... help New West Medicare ensure its members are provided ... unnecessary radiation. , Working closely with New West Medicare’s ... promoting the safe use of advanced imaging and provide ...
(Date:5/4/2015)... Sylvia Hawthorn-Deppen shared her experiences living with ... others in similar situations that they were not alone, in ... Discovery of New Energy” (published by Balboa Press). This year ... renewed press campaign. , “I have spent nearly 60 years ... says. “As an adolescent I got into trouble with an ...
(Date:5/4/2015)... Angeles, CA (PRWEB) May 04, 2015 ... Hinds, Eric Gladen’s documentary Trace Amounts, and Allison Folmar, ... annual autism conference held internationally. , On Sunday, May ... Is recovery from autism possible?" Are you interested in ... You’re In There: winning our war against autism ...
(Date:5/4/2015)... Angeles, California (PRWEB) May 04, 2015 ... a physician practice management firm in Los Angeles ... announced today the patent-pending status of The Sara Soulati ... by Soulati in 2010, is a lifestyle modification and ... in April 2015 to the U. S. Patents and ...
(Date:5/3/2015)... CA (PRWEB) May 03, 2015 Leading ... (CFHI), announced it will be awarding the 2015 Harris ... Knight and Selemawit Ghebrendrias, are the deserving recipients of ... for global service, Harris Llewellyn Wofford. The two recipients ... and passion for global health. , CFHI is ...
Breaking Medicine News(10 mins):Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2Health News:Author launches new press campaign for 2012 book ‘Wheel’ 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 4Health News:CEO Sara Soulati Announces Patent-Pending Designation For The Sara Soulati Health For Life Program 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 3
... by researchers at the Center for Injury Research and ... in emergency departments among children and adolescents between the ... According to the study, more than 4 million basketball-related ... study. While the number of injuries decreased 22 percent ...
... is the most common eye disorder in the world ... its genetic underpinnings. Scientists at Duke University Medical ... a gene associated with myopia in Caucasian people from ... Their work was published in Nature ...
... becomes riddled with clumps of protein, forming what are known as ... issue of Cell appears to have found a function ... prime ingredient in those plaques. It turns out that ... iron from an unsafe form to a safe one for transport ...
... September 10, 2010 (Toronto) Mental illness is ... condition, costing the Canadian economy $51 billion annually in lost ... the Centre for Addiction and Mental Health (CAMH) have calculated ... on average it,s double the cost of a leave for ...
... Researchers at New York University,s Center for Neural Science ... "lazy eye." Their findings, which appear in the most ... shed additional light on how amblyopia results from disrupted ... Amblyopia results from developmental problems in the brain. ...
... to assist the unemployed are failing job seekers with disabilities, ... of the Center for Research on Learning at the University ... Career Development Quarterly , shows two major federal programs ... recipients to find employment within two years, and the Workforce ...
Cached Medicine News:Health News:National study finds 70 percent increase in basketball-related traumatic brain injuries 2Health News:Gene discovery could yield treatments for nearsightedness 2Health News:Function found for Alzheimer's protein 2Health News:Mental health leaves most costly disability to Canadian employers 2Health News:NYU researchers identify new neurological deficit behind lazy eye 2Health News:Research shows unemployment programs lacking for people with disabilities 2
Sharp tip with cutting edge bent to 45 degrees. Fits 19 gauge or 20 gauge instrument port. 21 gauge x 25 mm. 10 per box....
80 inch PVC tubing with connectors and 19 gauge straight, beveled cannula. Fits Bausch & Lomb Surgical cassettes. Allows the safe removal of silicone oil in 10 minutes or less. 3/Box...
Angled, cannula with 32 gauge tip, 4 mm long, angled 65 degrees 1 mm from tip. 10 per box....
Accommodates either eye. Slotted, malleable aluminum surface. Correct size holes produce ideal pin hole effect. Packaged 50 per box....
Medicine Products: